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Background: Screening for prostate cancer (PC) may save lives, but overdiagnosis and overtreatment are serious drawbacks. We
aimed to determine men’s preferences for PC screening, and to elicit the trade-offs they make.
Methods: A discrete choice experiment (DCE) was conducted among a population-based random sample of 1000 elderly men
(55–75-years-old). Trade-offs were quantified with a panel latent class model between five PC screening aspects: risk reduction of
PC-related death, screening interval, risk of unnecessary biopsies, risk of unnecessary treatments, and out-of-pocket costs.
Results: The response rate was 46% (459/1000). Men were willing to trade-off 2.0% (CI: 1.6%–2.4%) or 1.8% (CI: 1.3%–2.3%) risk
reduction of PC-related death to decrease their risk of unnecessary treatment or biopsy with 10%, respectively. They were willing
to pay h188 per year (CI: h141–h258) to reduce their relative risk of PC-related death with 10%. Preference heterogeneity was
substantial, with men with higher educational levels having a lower probability to opt for PC screening than men with lower
educational levels.
Conclusion: Men were willing to trade-off some risk reduction of PC-related death to be relieved of the burden of biopsies or
unnecessary treatments. Increasing knowledge on overdiagnosis and overtreatment, especially for men with lower educational
levels, is warranted to prevent unrealistic expectations from PC screening.
Prostate cancer (PC) is a major health issue. Screening for PC
based on the prostate-specific antigen (PSA) test has potential to
save lives, but three out of every four men who undergo a
biopsy have a negative biopsy, as the PSA test lacks specificity
(Schroder et al, 2009). Additionally, the PSA test is poor at
discriminating between men with clinically significant cancer vs
those who have little to gain (Roobol et al, 2009). The PSA test may
detect small cancers that would never surface clinically during
lifetime. This overdiagnosis puts men at risk of treatment
complications.
Current PSA screening is hence unattractive due to over-
diagnosis and overtreatment. However, the decision to participate
or not in any screening programme is preferably based on an
individual decision-making process of weighting the test burden
against the potential benefits of screening. A man will make trade-
offs between what he perceives as the expected advantages and
disadvantages, e.g., how negative it would be if he were to suffer
from permanent erectile dysfunction due to PC screening.
Patients’ preferences can have a major impact on their
willingness to use health care services (Phillips et al, 2006). To
improve patient-centred health care it is important to investigate
men’s preferences for PC screening. Additionally, obtaining insight
into these preferences is relevant to inform clinicians and policy
decision makers, and for planning screening programmes.
However, quantitative studies investigating men’s preferences
for PC screening are lacking. We investigated the preferences
of men aged 55–75 years for PC screening. We hereto used a
discrete choice experiment (DCE), a quantitative approach that
is increasingly used in health care (Ryan and Gerard, 2003; de
Bekker-Grob et al, 2012).
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MATERIALS AND METHODS
Discrete choice experiment. In a DCE it is assumed that a
medical intervention, such as a screening programme, can be
described by its characteristics (attributes; e.g., screening interval)
(Ryan, 2004). Those characteristics are further specified by
variants of that characteristic (attribute levels; e.g., for screening
interval: every 2, 3, and 4 years). A second assumption is that the
individual’s preference for a medical intervention is determined by
the levels of those attributes (Ryan, 2004). The relative importance
of attributes and the trade-offs that respondents make between
them can be assessed by offering a series of choices between two or
more medical intervention alternatives with different combinations
of attribute levels (Hensher et al, 2005) (Appendix 1). In
comparison with other stated preference techniques, a DCE
presents a reasonably straightforward task and one which more
closely resembles a real-world decision (Mangham et al, 2009).
Attributes and levels. We used literature (Draisma et al, 2003;
Sennfalt et al, 2006; Andriole et al, 2009; Schroder et al, 2009;
Hugosson et al, 2010), interviews with experts in the field of PC
screening (n¼ 8) and men aged 55–75 years (n¼ 8; i.e., the target
group) to obtain insights into PC screening attributes and their
levels. We asked experts and men in the interviews to comment on
and complete the list of PC screening attributes that was created
from literature review. We also asked men to rank the attributes
from most important to less important with respect to their
preferences for PC screening. The number of attributes in a DCE is
limited (because of impact on the random component variability),
and the ranking results allowed us to make an a priori selection of
the five most relevant attributes: risk reduction of PC-related death,
screening interval, risk of unnecessary biopsies, risk of unnecessary
treatments, and out-of-pocket costs (Table 1). Unnecessary
biopsies and treatments are defined as unnecessary at the aggregate
level.
Study design and questionnaire. The combination of five
attributes with four levels each would result in 1024 (45) potential
PC screening alternatives. As it is not feasible to present a single
individual with all these alternatives, we generated a sample from
all these 1024 alternatives. We used an efficient design by
maximising D-efficiency (SAS software version 9.1, SAS Institute
Inc., Cary, NC, USA) (Street et al, 2005). Thirty-two choice sets
were constructed. As the cognitive burden may increase with the
number of choice sets beyond a certain threshold, the 32 choice
sets were blocked (Hensher et al, 2005) into two versions of
questionnaires containing 16 choice sets each (Bech et al, 2011).
Choice sets consisted of two PC screening alternatives and a ‘no PC
screening’ option to allow respondents to ‘opt out’ (Appendix 1).
The ‘opt out’ alternative was necessary as PC screening is a
preventive intervention and, as in real life, respondents are not
obliged to undertake PC screening. Respondents were asked to
consider all three alternatives in a choice set as realistic alternatives
and to choose the alternative that appealed most to them. The
questionnaire further contained questions on background variables
(e.g., age, educational level, generic health status) and a question
assessing experienced difficulty of the questionnaire (five-point
scale) (the complete questionnaire is available from the authors
on request). We conducted a pilot study (n¼ 10) to ascertain
respondents could manage the length of the questionnaire and to
examine the intelligibility, acceptability, and validity of the
questionnaire. As none of the respondents raised any problems,
no alterations were made.
Study sample. A representative sample of 1000 men aged 55–75
years was randomly recruited using the population registry of the
region Rijnmond in the Southwest of the Netherlands. Calculation
of optimal sample sizes is complicated as it depends on the true
values of the unknown parameters estimated in the discrete choice
models (Lancsar and Louviere, 2008). Earlier studies have shown
that sample sizes of 300–400 respondents are sufficient for reliable
statistical analyses (Bishop et al, 2004; Herbild et al, 2009; de
Bekker-Grob et al, 2010a). Therefore, taking into account an
expected response rate of 40% (Wordsworth et al, 2006; de Bekker-
Grob et al, 2010b), we recruited a representative sample of
n¼ 1000. We checked a posterior whether our sample size was
sufficient to find significant differences for each attribute(level) at a
5% level using the true values of the estimated parameters and
NGene software (http://www.choice-metrics.com/).
Invitation of subjects. Subjects were contacted by mail. They
received a questionnaire and an information brochure about PC
and PC screening. Individuals could return the questionnaire in a
postage-paid envelope that was included in the mailing package.
A reminder was sent 4 weeks later in case of non-response.
Approval for the study was obtained from the Medical Ethics
Committee, Erasmus MC (MEC-2010-316).
Statistical analyses. Several models exist to analyse discrete choice
data (see De Bekker-Grob et al. (2012) for an overview). Taking
our interest in preference heterogeneity into account, as well as our
sample size, a mixed logit model or a latent class model were both
good alternatives to analyse the choice observations. Although, the
best mixed logit model had a somewhat better model fit for
the choice observations than the best latent class model
(pseudo-R2¼ 0.42 vs 0.41 using NLogit software (http://www.lim-
dep.com/)), we preferred to use a latent class model due to its
advantages (Swait, 1994). A latent class model can be used to
identify the existence and the number of segments or classes, C,
in the population (i.e., identifying different utility (preference)
Table 1. Considered attributes and attribute levels for prostate cancer
screening
Attributesa Levels
Risk reduction of death from prostate
cancer
3.5% - 3.2% (10% relative risk
reduction)
3.5% - 2.8% (20% relative risk
reduction)
3.5% - 2.5% (30% relative risk
reduction)
3.5% - 1.8% (50% relative risk
reduction)
Screening interval Every year
Every 2 years
Every 3 years
Every 4 years (reference level)












aAll attributes entered the analyses as numerical variates, except the attribute ‘screening
interval’. This latter attribute was entered the analyses as a categorical variate with ‘every 4
years’ as reference level.
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functions across unobserved subgroups). Class membership is latent
in that each respondent belongs to each class up to a modelled
probability and not deterministically assigned by the analyst a priori.
The model is flexible in that the probability that sampled
respondents belong to a particular class can be linked to covariates
(e.g., age, income), hence allowing for some understanding as to the
make-up of the various class segments (see Appendix 2 for more
details). This additional information can be really useful for
physicians, and counterbalance the somewhat lower model fit
compared with the best mixed logit model. Further, outside of the
health care literature, there is growing anxiety as to the appropriate
use of outputs from the mixed logit model (Daly et al, 2012). The
use of the latent class model, overcomes this issue, while still
allowing for all of the advantages of the mixed logit model.
We used a panel latent class model. A panel latent class model
accounts for the panel nature of the data as each respondent
completed 16 choice tasks. In order to determine the number of
classes, we selected the model with the best fit based on the AIC
criterion. We tested a number of different specifications for the
utility function (e.g., categorical or numerical attribute levels, two-
way interactions between attributes, several attribute transforma-
tions). The optimal utility function was:
Vnsj j c¼b0 j cþb1 j c reduction of deathsnsj j cþb2 j cintervalð1yrÞnsj j c
þb3 j cintervalð2yrsÞnsj j cþb4 j cintervalð3yrsÞnsj j cþb5 j cbiopsynsj j c
þb6 j ctreatmentnsj j cþb7 j ccostsnsj j cþb8 j creduction of deathsnsj j c
costsnsj j cþb9 j cbiopsynsj j ccostsnsj j cþb10 j ctreatmentnsj j c
costsnsj j cþb11 j creduction of deathsnsj j cbiopsynsj j c
þb12 j ccosts2nsj j cþb13 j creduction of deaths2nsj j c
ð1Þ
where
Vnsj|c represent the observable utility that respondent n
belonging to class segment c has for alternative j in
choice set s;
b0|c represents an alternative-specific constant for a certain
class;
b1-7|c are class-specific parameter weights (coefficients) line-
arly associated with each attribute of the DCE;
b8-11|c are class-specific two-way interaction effects (i.e., an
effect where the influence of one attribute depends on
the level of another attribute); and
b12-13|c are class-specific parameter weights associated with
attribute transformations.
In addition to the utility function, the final model allowed for
several covariates (education, depressed/anxious feelings, and
stated willingness to pay (WTP) for PC screening) to enter into
the class assignment model (Appendix 2). The class assignment
utility function for the final model was (see Equation (2)):
Vnc¼b0cþb1c higher educationn
þb2c depressionnþb3c wtpð100 eurosÞn
ð2Þ
For the class coefficients, the statistical significance of a
coefficient (P-value p0.05) indicates that conditional to belonging
to that class, respondents considered the attribute important in
making their choices in the DCE. The sign of the coefficient reflects
whether the attribute has a positive or negative effect on utility. We
expected that only the attribute ‘risk reduction of PC-related death’
and one or more levels of ‘screening interval’ would have a positive
effect (i.e., a positive sign) (Hol et al, 2010; van Dam et al, 2010). In
terms of the class assignment parameters, statistically significant
parameter estimates indicate that the associate covariate can be
used to help in understanding the different segments. For example,
if the depression parameter associated with a particular class in the
assignment model is positive and significant, then this is indicative
that people who suffer depression are more likely to belong to that
particular class as given in Equation (1).
Trade-offs. We calculated the WTP values for each of the
attributes. A WTP value represents how much one is willing to
pay for a one unit change in the attribute of interest, and is
calculated by taking the ratio of the parameter for attribute k to the
parameter related to cost. For the latent class model however,
several potential WTP measures can be derived. Firstly, it is
possible to calculate the conditional class WTP values. In the
model, each class will have a set of parameter estimates associated
with Equation (1). As such, conditional to belonging to class c, the





While of theoretical interest, the WTP measures derived from
Equation (3) are likely to be of limited relevance to the analyst.
This is because the model assumes that respondents belong to all
classes up to a probability (and not to just one class). It is possible
however to obtain overall WTP measures by weighting the
conditional WTP values by the probability that respondents
belongs to a given class (given by the class assignment probability








In the current paper, we compute the latter marginal WTP
values. We also compute the confidence intervals based on the
individual-specific WTP estimates using the Krinsky and Robb
procedure (Krinsky and Robb, 1986).
RESULTS
Respondents. The response rate to the questionnaire was 459/
1000 (46%, Figure 1). Respondents did not differ from non-
respondents in age (P¼ 0.62) or marital status (0.44). Of the 459
respondents, 427 (93%) completed the DCE task. These respon-
dents had a mean age of 63.3 years (s.d.¼ 5.2), one-third had a
459 (46%) Men responded to the questionnaire
32 Men did not complete the DCE
task
431 Did not respond
4 Disabled persons
101 Did not want to participate




Survey sent to 1000 men
(aged 55–75 years)
Figure 1. Overview of subjects accessing the study.
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higher educational level, and they lived predominantly together
with a partner. Three per cent had been treated for PC (Table 2).
Discrete choice experiment results. Three classes were identified
(Table 3). The average class probabilities within the sampled
population were 60.8%, 23.0%, and 16.2% for latent class 1, 2, and
3 respectively. However, the probability to belong to a specific class
depended on the educational level of the respondent, whether he
had anxiety/depression feelings, and his stated WTP for receiving a
PC screening programme (not to be confused with the derived
WTP value obtained from the model; see Equation (3)). To be
more precise, respondents who had a higher educational level, had
a higher probability to belong to latent class 3; respondents, who
were willing to pay for PC screening had a higher probability to
belong to latent class 1; whereas respondents who had anxiety/
depression feeling had a higher probability to belong to latent class
3. Hence, taking all these patient characteristics into account,
respondents, who had a lower educational level, did not have
anxiety/depression feelings, and were willing to pay for PC
screening, had a higher probability to belong to latent class 1
(68.1%, 21.4%, and 10.5% for latent class 1, 2, and 3 respectively).
However, if respondents had a lower educational level, had anxiety/
depression feelings and were not willing to pay for PC screening,
the probability to belong to latent class 2 was the highest (28.3%,
40.1%, and 31.6% for latent classes 1, 2, and 3, respectively).
Respondents with a higher educational level, who had anxiety or
depression feelings, and were not willing to pay for PC screening,
had the highest probability to belong to latent class 3 (20.8%,
30.7%, and 48.6% for latent class 1, 2, and 3 respectively).
The estimated coefficients for each latent class had the expected
sign and were significant in most cases (Table 3) and showed,
therefore, theoretical validity. The positive sign given to the
coefficient ‘risk reduction of PC-related death’ indicated that men
preferred a PC screening programme generating a higher reduction
of PC-related death over a PC screening programme that generates
a lower reduction of PC-related death. The negative signs for ‘risk
of unnecessary treatment and biopsy’ and ‘out-of-pocket costs’
indicate that men preferred a PC screening programme with a low
risk of unnecessary treatment and biopsy, and low out-of-pocket
costs.
All five PC screening aspects significantly influenced men’s
preferences, although the preference heterogeneity was substantial.
Nevertheless, irrespective of the latent class respondents belong to,
risk reduction of PC death, risk of unnecessary treatment and
biopsy, as well as costs, they were all important for respondents’
preferences, whereas screening interval was not. Respondents who
belong to latent class 1 showed a strong preference for a shorter
screening interval. Although respondents who belong to latent
class 3 also showed a preference for screening every 2 years over
screening every 4 years, such respondents significantly preferred
screening every 4 years over screening every year. In contrary, for
latent class 2 the screening interval did not have an influence on
preferences for PC screening at all.
Assuming a realistic PC screening programme (i.e., 20% risk
reduction of PC-related death, screening interval every 4 years,
60% risk of an unnecessary biopsy, 50% risk of an unnecessary
treatment, and no out-of-pocket costs) the utilities were 2.7, 4.6,
and  0.6 based on latent class 1, 2, and 3 respectively (see
Equation (1) and Table 3). That is, respondents belonging to latent
class 1 or 2 preferred this realistic PC screening scenario over no
screening (V¼ 2.74V¼ 0; and V¼ 4.64V¼ 0 respectively).
However, respondents belonging to latent class 3 did not prefer
this PC screening programme over no screening (V¼  0.6
oV¼ 0). More general, assuming realistic attribute levels of PC
screening, men with a lower educational level had a higher
probability to prefer PC screening over no PC screening compared
with men with a higher educational level, all else being equal. The
same conclusion can be made for men who were willing to pay for
PC screening or for men without anxiety/depressed feelings. That
is, men who were willing to pay for PC screening and/or did not
have anxiety/depressed feelings, had a higher probability to prefer
PC screening over no PC screening compared with men who were
not willing to pay for PC screening and/or had anxiety/depressed
feelings, all else being equal.
Trade-offs
Willingness to pay. Based on the expressed preferences, men were
willing to pay h188 per year (CI: h141–h258) to reduce their
relative risk of PC-related death with 10% (Table 4). They were
willing to pay h33 per year (CI: h23–h48) to decrease their risk of
unnecessary biopsy with 10%, h38 per year (CI: h27–h53) to
decrease their risk of unnecessary treatment with 10%, or h87 per
year (CI: h48–h137) to get a PC screening programme with a
screening interval of every 2 years instead of every 4 years. The
wide range of CIs showed that the difference in WTP was
considerable, which proved the existence of preference
heterogeneity.





Age (years) 63.3 5.2
Educational level n %
Lower education 95 22.5
Intermediate education 188 44.4
Higher education 140 33.1
Household
Single, no living in children 41 9.6
Single, one or more living in children 6 1.4
With partner/family member, no living in
children
298 70.1









Treated for prostate cancer
Yes 13 3.1
No 407 96.9
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Willingness to trade of risk reduction of PC-related death. Men
were willing to trade-off 2.0% (CI: 1.6%–2.4%) risk reduction of
PC-related death to decrease their risk of unnecessary treatment
with 10%, 1.8% (CI: 1.3% to 2.3%) to decrease their risk of
unnecessary biopsy with 10%, or 4.6% (CI: 2.8% to 6.4%) to get a
PC screening programme with an screening interval of every 2
years instead of every 4 years (Table 5). Again, the wide range of
CIs regarding the willingness to trade of risk reduction of PC-
related death proved the existence of preference heterogeneity.
DISCUSSION
Risk reduction of PC-related death, screening interval, risk of
unnecessary biopsies and treatments, and out-of-pocket costs, all
influenced men’s preferences for PC screening. However, sub-
stantial preference heterogeneity existed. Assuming a realistic PC
screening programme, men with a lower educational level had a
higher probability to opt for PC screening than men with a higher
Table 3. Men’s preferences for prostate cancer screening based on a panel latent class logit model with three latent classes
Latent class 1 Latent class 2 Latent class 3
Attribute Coefficient t-ratio Coefficient t-ratio Coefficient t-ratio
Constant 3.16*** 9.71 4.67*** 13.50  0.65*  1.90
Risk reduction of PC death (per 10%) 0.93*** 8.63 0.40*** 2.90 0.82*** 5.24
Screening interval
Every year 0.10** 1.99  0.05 0.77  0.20**  2.43
Every 2 years 0.20*** 3.97 0.09 1.47 0.21*** 2.89
Every 3 years 0.02  0.31  0.02 0.24 0.07  0.84
Risk unnecessary biopsy (per 10%) 0.10**  2.57  0.27*** 6.09 0.03  0.70
Risk unnecessary treatment (per 10%) 0.10***  5.30  0.04* 1.77  0.17***  8.67
Out-of-pocket costs (per h100) 0.07 0.40  1.32*** 5.40  1.10***  4.65
Risk reduction PC death costs 0.06*** 2.72  0.01 0.09 0.02 0.59
Biopsy costs 0.07*** 3.37 0.04 1.61 0.03 1.12
Treatment costs 0.01  0.35 0.05** 2.33 0.05*** 3.09
Risk reduction PC deathbiopsy 0.02**  1.99 0.07*** 5.59  0.03**  2.29
Costs2 0.07***  5.16 0.01 0.28 0.10** 2.19
Risk reduction PC death2 0.18***  5.98 0.03 1.55  0.06***  3.33
Class probability model
Constant 1.62*** 7.03 0.69*** 2.68 — —
Higher eduction 0.74**  2.35  0.70* 1.86 — —
Depression 1.73***  3.88  0.45 1.00 — —
Willingness to pay (per h100) 0.25** 2.97 0.02 0.29 — —
Class probability






Abbreviations: Coeff.¼ coefficient; PC¼prostate cancer. ***, **, * denotes significance at 1%, 5%, and 10%, respectively. Effects coded variable used for frequency of a blood test (reference
level¼ screening every 4 years; the value of this level equals the negative sum of the coefficients of the included attribute levels). Number of observations¼ 6.669.
Table 4. Willingness to pay to achieve an improvement in one of the prostate screening attributes
Attribute WTP (h; CI) To receive a screening programme
Mortality reduction 187.6 (140.6 to 257.8) With 10% more prostate cancer-related mortality reduction
Screening interval 9.7 (24.9 to 46.5) Every year instead of every 4 years
86.9 (48.2 to 136.8) Every 2 years instead of every 4 years
 12.0 ( 50.2 to 27.4) Every 3 years instead of every 4 years
Unnecessary treatment 37.6 (26.7 to 53.0) With 10% less risk of unnecessary treatments
Unnecessary biopsy 33.4 (22.5 to 48.4) With 10% less risk of unnecessary biopsies
Abbreviations: CI¼ confidence interval; h¼ euro; WTP¼willingness to pay. CI¼ 95% confidence interval based on the Krinsky Robb method adjusted for class probabilities. The average values
of the interactions are taken into account (i.e., costs¼h112.50; mortality reduction¼ 27.5%; unnecessary treatment¼ 37.5%; unnecessary biopsy¼ 50%).
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educational level. This same phenomenon was found for men who
were willing to pay for PC screening and/or did not have anxiety/
depressed feelings. Men were willing to pay h188 per year (CI:
h141–h258) for each 10% reduction in their relative risk of PC-
related death with 10%, or h87 per year (CI: h48–h137) to get PC
screening every 2 years instead of 4 years. Men were willing to
trade-off 2.0% (CI: 1.6%–2.4%) or 1.8% (CI: 1.3%–2.3%) risk
reduction of PC-related death to decrease their risk of unnecessary
treatment or unnecessary biopsy with 10%, respectively.
There are no previous DCEs investigating how characteristics of
PC screening determine men’s preferences for participation in PC
screening. However, a study that investigated the influence of
information on preferences among men aged 50–70 years for
introducing PC screening in Denmark, found that regardless of
information level a PC screening programme was valued highly
(Pedersen et al, 2011). These results are in line with our findings,
which show that in general men had a positive attitude towards PC
screening. Our finding that men were prepared to give up life
expectancy to avoid side-effects of medical intervention was also
found by a DCE who focused on patients’ preferences for the
management of non-metastatic PC (Sculpher et al, 2004).
Although PC screening intervals may differ among countries,
the most widely used screening interval is screening every 4 years
(Schröder et al, 2009). Our study showed that men preferred a
shorter screening interval over a longer screening interval. These
results are in line with other studies. In a cancer screening context,
a DCE showed that people aged 50–75 years significantly preferred
colorectal cancer screening intervals shorter than 10 years over a
10-year screening interval (van Dam et al, 2010). Preferring a
shorter screening interval over a longer screening interval was also
found in another DCE study (Wordsworth et al, 2006), where
women preferred more frequent cervical cancer screening. Several
studies have shown that reassurance may be a motivation for and/
or a result of undergoing cancer screening (Cantor et al, 2002;
Whynes et al, 2007). This stresses the importance of adequate
information provided to potential screeners.
Men included in our study population showed preference
heterogeneity for PC screening aspects. Information about
preference heterogeneity may help physicians to understand
individuals’ preferences for screening. Awareness of and explicit
addressing differences in personal values regarding screening in
general may have a positive effect on the process and outcomes of
screening initiation in individual patients. For example, our results
showed that men with lower educational levels had a higher
probability to prefer PC screening than men with higher
educational levels. The implications are that physicians (1) should
be aware that patients may overestimate their benefit of PC
screening due to numeracy problems, (2) can have a role to prevent
unrealistic expectations from PC screening, and (3) are able to
reach an optimal shared decision-making regarding PC screening.
Additionally, information about preference heterogeneity may also
be useful to inform policy decisions. Tailored PC screening
programmes may result in a better informed decision-making for
screening. Noteworthy, as physicians and patients may differ on
the desirability for PC screening, which may hamper the process
and outcome of shared decision-making, further research about
determining and comparing physicians’ and men’s preferences for
prostate screening is recommended.
The present study had several limitations. First, the response
rate of 46% was higher than expected and similar to other DCE
studies (Ratcliffe et al, 2002; Hundley and Ryan, 2004; Wordsworth
et al, 2006; de Bekker-Grob et al, 2010b), but this response rate is
still not optimal. We cannot exclude selection bias, although our
respondents did not differ from non-respondents in age or marital
status. Additionally, the proportions of different educational levels
in our study sample were quite similar with the general population.
Second, the inclusion of numbers and rates in our DCE might have
caused problems with understanding the choice task. However,
93% of the respondents passed the rationality test that was
included in the questionnaire, and 76% of the respondents did not
find the DCE questions difficult. We hence believe that this has not
influenced the results to a large extent. Finally, the current results
could gain credibility if it were possible to compare the stated
preferences of men with their actual behaviour in a PC screening
programme.
In conclusion, men are willing to trade-off some risk reduction
of PC-related death to be relieved of the burden of biopsies or to
avoid unnecessary treatments. Men with lower educational levels
have a higher probability to prefer PC screening than men with
higher educational levels. Increasing knowledge on overdiagnosis
and overtreatment, especially for men with lower educational
levels, is hence warranted to prevent unrealistic expectations from
PC screening.
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APPENDIX 1
Example of a choice set
Thirty-five out of every 1000 men that will die is caused by PC. Which alternative do you prefer to reduce your risk to die from PC: no
screening, screening programme 1, or screening programme 2? (please, tick one box)
NO SCREENING PROGRAM 1 PROGRAM 2
Amount of men per
1,000 men that will die










Frequency of a blood
test
No blood test Every 4 year a 
blood test
Every 3 year a 
blood test
Amount of men per




(=no cancer detected, 
although the blood test 
suggested that a 
biopsy was needed) 








Amount of men per 
1,000 treated men that 
receive an unnecess- 
ary treatment
(=no increase in life 
expectancy, but there 
is a risk of remaining 
urine incontinence and 
erection problems due 
to treatment) 
Not applicable 0 unnecessary 
treatments






Out of pocket cost 
per year during the 












Latent class model. The probability that respondent n belongs to




c¼1 exp yc0qnc0ð Þ
ðiÞ
where qnc represents covariates (e.g., age, income), and
yc represents parameters to be estimated. If no covariates are
included in the class assignment model, then the model can be
estimated with constants only. In such a case, all respondents will
have the same probability of belonging to a given class or segment.
When covariates are included in the class assignment model,
the class membership probability will differ depending on the
covariates included in the model. For model identification, the
parameters (and/or constants) for one class are required to be set
to zero, such that all the remaining parameters are interpreted as
being relative to this class. Note that in estimating the model, the
analyst must a priori determine the number of classes to be
estimated.
Conditional on belonging to a given class c, the probability that
individual n chooses alternative j in choice set s is given as
Pnsj j c¼
exp bk j cxnsjk
 
PJ
i¼1 exp bk j cxnsik
  ðiiÞ
where bk j c represent class-specific parameter estimates to be
estimated and xnsjk represent the attributes associated with the
alternatives described within the DCE.
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Panel latent class model. Panel latent class model means that the
model accounts for the pseudo panel nature of the DCE data as
each respondent completed several choice tasks. In the DCE
employed herein, each respondent completed 16 choice tasks. As
such, the probability that a respondent is observed to make a
particular sequence of choices over the 16 choice tasks, conditional




exp bk j cxnsjk
 
PJ








Given Equation (iii), we use maximum likelihood estimation to
locate the parameters of interest, yc and bk j c. We do this maximising












where ynjs is an indicated variable equal to one if alternative j was
observed to be chosen by respondent n in choice set s, or zero
otherwise.
By making use of the product of the probabilities (Equation (iii))
in the log-likelihood function (Equation (iv)), as opposed to the
individual choice set probabilities (Equation (ii)), the model
estimates the probability of observing sequence of choices made
over the 16 choice tasks. As such, the model accounts for the
pseudo panel nature of the DCE data.
Class assignment utility functions. In addition to the conditional
utility functions, the final model allowed for several covariates to
enter into the class assignment model (Equation (i)). The class
assignment utility function for the final model is given as
Equation (v).
Vnc¼b0cþb1c higher educationnþb2c depressionn
þb3cwtpð100 eurosÞn
: ðvÞ
The parameter estimates of Equation (v) are obtained by
maximising Equation (iv), given the data.
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